Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.44
+0.24 (2.93%)
At close: Jun 26, 2026, 4:00 PM EDT
8.41
-0.03 (-0.36%)
After-hours: Jun 26, 2026, 7:01 PM EDT
Kyverna Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Kyverna Therapeutics stock have an average target of 30, with a low estimate of 25 and a high estimate of 33. The average target predicts an increase of 255.45% from the current stock price of 8.44.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kyverna Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $33 | Buy | Maintains | $33 | +291.00% | Jun 4, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +196.21% | Jun 3, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $30 → $29 | Buy | Reiterates | $30 → $29 | +243.60% | May 13, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $33 | Buy | Reiterates | $33 | +291.00% | May 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
17.60M
EPS This Year
-2.88
from -3.64
EPS Next Year
-2.95
from -2.88
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 41.1M | |
| Avg | n/a | 17.6M | |
| Low | n/a | 4.3M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 263.7% |
| Avg | - | 202.2% |
| Low | - | 125.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.59 | -2.15 | |
| Avg | -2.88 | -2.95 | |
| Low | -3.03 | -3.82 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.